United States Biotechnology & Medical Research

Protagenic Therapeutics Inc (PTIX)

Track

Track

Over the past ninety days, Protagenic Therapeutics Inc. witnessed seven purchase transactions by Executive Chair Garo H. Armen. These acquisitions totaled approximately $30,717, reflecting increased confidence from leadership. This activity occurred amidst a 287% stock price surge, preceding the most recent results financiers report.
Ticker: PTIX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Protagenic Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.4
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF Executive Director
Transaction date
Purchase
Price
402.65
Quantity 3,247 -20.9%
Value US$1,197,157
2.4
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF Executive Director
Transaction date
Purchase
Price
201.54
Quantity 65,878 -38.8%
Value US$2,247,561
2.4
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF Executive Director
Transaction date
Purchase
Price
336.99
Quantity 31,225 -16.9%
Value US$3,313,572
2.4
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF Executive Director
Transaction date
Purchase
Price
0.32
Quantity 2,220 +6.9%
Value US$710
2.4
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF Executive Director
Transaction date
Purchase
Price
0.22
Quantity 685 +2.2%
Value US$151
2.4
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF Executive Director
Transaction date
Purchase
Price
0.26
Quantity 5,000 +19.0%
Value US$1,294
2.4
ARMEN GARO H EXEC. CHAIR & PRINCIPAL OFF. Executive Director
Transaction date
Purchase
Price
0.18
Quantity 26,291 +inf%
Value US$4,806
2.7
Arrow Alexander K. Chief Financial Officer Officer
Transaction date
Purchase
Price
0.81
Quantity 8,000 +21.2%
Value US$6,480
2.7
Arrow Alexander K. Chief Financial Officer Officer
Transaction date
Purchase
Price
0.72
Quantity 8,000 +5.6%
Value US$5,760
2.7
Arrow Alexander K. Chief Financial Officer Officer
Transaction date
Purchase
Price
0.71
Quantity 23,000 +19.1%
Value US$16,330
2.7
Arrow Alexander K. Chief Financial Officer Officer
Transaction date
Purchase
Price
2.29
Quantity 1,000 +0.8%
Value US$2,290
2.7
Arrow Alexander K. Chief Financial Officer Officer
Transaction date
Purchase
Price
2.29
Quantity 1,000 +0.8%
Value US$2,290
ARMEN GARO H See Remarks Executive Director Large shareholder
Transaction date
Purchase
Price
1.25
Quantity 60,211 +1.4%
Value US$75,264
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
2.09
Quantity 1,758 +0.4%
Value US$3,674
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
2.08
Quantity 300 +0.1%
Value US$624
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
2.07
Quantity 569 +0.1%
Value US$1,178
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
2.00
Quantity 74 +0.0%
Value US$148
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.99
Quantity 1,334 +0.3%
Value US$2,655
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.98
Quantity 900 +0.2%
Value US$1,782
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.97
Quantity 266 +0.1%
Value US$524
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.90
Quantity 5,000 +1.1%
Value US$9,500
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.79
Quantity 3,499 +0.8%
Value US$6,263
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.70
Quantity 100 +0.0%
Value US$170
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.64
Quantity 100 +0.0%
Value US$164
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.63
Quantity 600 +0.1%
Value US$978
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.60
Quantity 300 +0.1%
Value US$480
MUSCI RAYMOND Exec VP, Corporate Development Executive Director
Transaction date
Purchase
Price
1.59
Quantity 200 +0.0%
Value US$318
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.60
Quantity 5,376 +0.2%
Value US$3,226
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.65
Quantity 527,683 +20.4%
Value US$342,888
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.67
Quantity 21,947 +0.9%
Value US$14,704
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.66
Quantity 86,386 +3.5%
Value US$56,989
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.85
Quantity 25,000 +1.0%
Value US$21,250
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.85
Quantity 50,500 +2.1%
Value US$42,925
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.86
Quantity 50,000 +2.1%
Value US$42,920
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.85
Quantity 11,100 +0.5%
Value US$9,435
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
1.17
Quantity 25,000 +1.1%
Value US$29,290
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.03
Quantity 25,000 +1.1%
Value US$100,655
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.30
Quantity 10,000 +0.4%
Value US$42,968
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.36
Quantity 10,000 +0.4%
Value US$43,601
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.31
Quantity 10,000 +0.4%
Value US$43,107
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.21
Quantity 10,000 +0.4%
Value US$42,071
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.00
Quantity 35,000 +1.6%
Value US$140,000
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
4.56
Quantity 35,000 +1.6%
Value US$159,750
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
14.00
Quantity 12,500 +0.8%
Value US$175,000
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.01
Quantity 360,000,000 +516.1%
Value US$3,492,000
Trinad Capital Master Fund Ltd. Large shareholder
Transaction date
Purchase
Price
0.01
Quantity 360,000,000 +516.1%
Value US$3,492,000
Banon Sid Former Director
Transaction date
Sale
Price
0.02
Quantity 586,222 -90.8%
Value US$11,724
CHAZEN JEROME A Non-Executive Director
Transaction date
Sale
Price
0.02
Quantity 2,344,887 -90.8%
Value US$46,898
KIER ISAAC Non-Executive Director
Transaction date
Sale
Price
0.02
Quantity 17,586,652 -90.8%
Value US$351,733
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-24 2026-08-21 B Purchase
2.4
ARMEN GARO H

EXEC. CHAIR & PRINCIPAL OFF

Executive Director
3,247 -20.9%
402.65
US$1,197,157 		3,247 -20.9% 402.65 US$1,197,157
2026-08-20 2026-08-20 B Purchase
2.4
ARMEN GARO H

EXEC. CHAIR & PRINCIPAL OFF

Executive Director
65,878 -38.8%
201.54
US$2,247,561 		65,878 -38.8% 201.54 US$2,247,561
2026-08-20 2026-08-19 B Purchase
2.4
ARMEN GARO H

EXEC. CHAIR & PRINCIPAL OFF

Executive Director
31,225 -16.9%
336.99
US$3,313,572 		31,225 -16.9% 336.99 US$3,313,572
2026-08-12 2026-08-11 B Purchase
2.4
ARMEN GARO H

EXEC. CHAIR & PRINCIPAL OFF

Executive Director
2,220 +6.9%
0.32
US$710 		2,220 +6.9% 0.32 US$710
2026-08-10 2026-08-06 B Purchase
2.4
ARMEN GARO H

EXEC. CHAIR & PRINCIPAL OFF

Executive Director
685 +2.2%
0.22
US$151 		685 +2.2% 0.22 US$151
2026-08-06 2026-08-05 B Purchase
2.4
ARMEN GARO H

EXEC. CHAIR & PRINCIPAL OFF

Executive Director
5,000 +19.0%
0.26
US$1,294 		5,000 +19.0% 0.26 US$1,294
2026-08-03 2026-07-30 B Purchase
2.4
ARMEN GARO H

EXEC. CHAIR & PRINCIPAL OFF.

Executive Director
26,291 +inf%
0.18
US$4,806 		26,291 +inf% 0.18 US$4,806
2023-10-13 2023-10-12 B Purchase
2.7
Arrow Alexander K.

Chief Financial Officer

Officer
8,000 +21.2%
0.81
US$6,480 		8,000 +21.2% 0.81 US$6,480
2022-05-18 2022-05-18 B Purchase
2.7
Arrow Alexander K.

Chief Financial Officer

Officer
8,000 +5.6%
0.72
US$5,760 		8,000 +5.6% 0.72 US$5,760
2022-05-18 2022-05-17 B Purchase
2.7
Arrow Alexander K.

Chief Financial Officer

Officer
23,000 +19.1%
0.71
US$16,330 		23,000 +19.1% 0.71 US$16,330
2021-05-03 2021-04-30 B Purchase
2.7
Arrow Alexander K.

Chief Financial Officer

Officer
1,000 +0.8%
2.29
US$2,290 		1,000 +0.8% 2.29 US$2,290
2021-05-03 2021-04-29 B Purchase
2.7
Arrow Alexander K.

Chief Financial Officer

Officer
1,000 +0.8%
2.29
US$2,290 		1,000 +0.8% 2.29 US$2,290
2016-08-18 2016-06-17 B Purchase ARMEN GARO H

See Remarks

Executive Director Large shareholder
60,211 +1.4%
1.25
US$75,264 		60,211 +1.4% 1.25 US$75,264
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
1,758 +0.4%
2.09
US$3,674 		1,758 +0.4% 2.09 US$3,674
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
300 +0.1%
2.08
US$624 		300 +0.1% 2.08 US$624
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
569 +0.1%
2.07
US$1,178 		569 +0.1% 2.07 US$1,178
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
74 +0.0%
2.00
US$148 		74 +0.0% 2.00 US$148
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
1,334 +0.3%
1.99
US$2,655 		1,334 +0.3% 1.99 US$2,655
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
900 +0.2%
1.98
US$1,782 		900 +0.2% 1.98 US$1,782
2010-12-15 2010-12-13 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
266 +0.1%
1.97
US$524 		266 +0.1% 1.97 US$524
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
5,000 +1.1%
1.90
US$9,500 		5,000 +1.1% 1.90 US$9,500
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
3,499 +0.8%
1.79
US$6,263 		3,499 +0.8% 1.79 US$6,263
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
100 +0.0%
1.70
US$170 		100 +0.0% 1.70 US$170
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
100 +0.0%
1.64
US$164 		100 +0.0% 1.64 US$164
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
600 +0.1%
1.63
US$978 		600 +0.1% 1.63 US$978
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
300 +0.1%
1.60
US$480 		300 +0.1% 1.60 US$480
2010-12-15 2010-12-10 B Purchase MUSCI RAYMOND

Exec VP, Corporate Development

Executive Director
200 +0.0%
1.59
US$318 		200 +0.0% 1.59 US$318
2010-01-07 2009-12-21 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
5,376 +0.2%
0.60
US$3,226 		5,376 +0.2% 0.60 US$3,226
2010-01-07 2009-12-14 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
527,683 +20.4%
0.65
US$342,888 		527,683 +20.4% 0.65 US$342,888
2010-01-07 2009-12-09 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
21,947 +0.9%
0.67
US$14,704 		21,947 +0.9% 0.67 US$14,704
2010-01-07 2009-12-08 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
86,386 +3.5%
0.66
US$56,989 		86,386 +3.5% 0.66 US$56,989
2010-01-07 2009-11-19 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
25,000 +1.0%
0.85
US$21,250 		25,000 +1.0% 0.85 US$21,250
2010-01-07 2009-11-16 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
50,500 +2.1%
0.85
US$42,925 		50,500 +2.1% 0.85 US$42,925
2010-01-07 2009-11-13 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
50,000 +2.1%
0.86
US$42,920 		50,000 +2.1% 0.86 US$42,920
2010-01-07 2009-11-12 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
11,100 +0.5%
0.85
US$9,435 		11,100 +0.5% 0.85 US$9,435
2008-11-26 2008-11-25 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
25,000 +1.1%
1.17
US$29,290 		25,000 +1.1% 1.17 US$29,290
2008-09-03 2008-08-29 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
25,000 +1.1%
4.03
US$100,655 		25,000 +1.1% 4.03 US$100,655
2008-06-17 2008-06-13 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.30
US$42,968 		10,000 +0.4% 4.30 US$42,968
2008-06-12 2008-06-11 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.36
US$43,601 		10,000 +0.4% 4.36 US$43,601
2008-06-12 2008-06-10 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.31
US$43,107 		10,000 +0.4% 4.31 US$43,107
2008-06-09 2008-06-05 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
10,000 +0.4%
4.21
US$42,071 		10,000 +0.4% 4.21 US$42,071
2008-06-02 2008-06-02 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
35,000 +1.6%
4.00
US$140,000 		35,000 +1.6% 4.00 US$140,000
2008-06-02 2008-05-30 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
35,000 +1.6%
4.56
US$159,750 		35,000 +1.6% 4.56 US$159,750
2007-12-03 2007-11-30 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
12,500 +0.8%
14.00
US$175,000 		12,500 +0.8% 14.00 US$175,000
2007-03-06 2007-02-12 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
360,000,000 +516.1%
0.01
US$3,492,000 		360,000,000 +516.1% 0.01 US$3,492,000
2007-03-06 2007-02-12 B Purchase Trinad Capital Master Fund Ltd. Large shareholder
360,000,000 +516.1%
0.01
US$3,492,000 		360,000,000 +516.1% 0.01 US$3,492,000
2006-10-27 2006-10-24 S Sale Banon Sid

Former Director
586,222 -90.8%
0.02
US$11,724 		586,222 -90.8% 0.02 US$11,724
2006-10-27 2006-10-24 S Sale CHAZEN JEROME A Non-Executive Director
2,344,887 -90.8%
0.02
US$46,898 		2,344,887 -90.8% 0.02 US$46,898
2006-10-26 2006-10-24 S Sale KIER ISAAC Non-Executive Director
17,586,652 -90.8%
0.02
US$351,733 		17,586,652 -90.8% 0.02 US$351,733
Explore more

More insider trading research around Protagenic Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America